Steven Reed is the founder of HDT Bio. He leads the company's work on mRNA vaccines for cancer prevention and treatment, including the AMPLIFY platform.
Steven Reed is the co-founder, President, and CEO of HDT Bio, a Seattle-based clinical-stage biopharmaceutical company founded in 2018. He leads the company's work on mRNA vaccines for cancer prevention and treatment, including the AMPLIFY platform, and has also been involved in developing a novel tuberculosis vaccine.
Full founder directory · Investor directory · Company funding database · Fundraising library